Refine by MP, party, committee, province, or result type.
Health committee Perhaps I'll ask my colleague, Dr. Bell, to answer that. She has extensive experience with clinical research and the medical application of work—
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Sorry. I was just passing it to Dr. Bell, who is better positioned than I am to answer the question.
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Not to my knowledge, no, but of course, one of the themes here is that there is still lots we don't know. No, at this point here, it's my understanding there—
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Absolutely. At this point here, I'm not aware of any of what we call more severe strains caused by mutations, but if one were to emerge, we'd want to catch it pretty fast.
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee It's gets into a little bit of a definitional problem, I guess, and what you call a strain. There are thousands of variants now that you can distinguish, based on these mutations. I don't know whether they've been classified into distinct strains. I would defer to my colleagues,
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Perhaps I'll add a perspective from Genome Canada. We're not on the vaccine development side, but the network we're leading is going to be developing and generating an immense amount of data around both the virus and the number of the patients. Everybody who is involved, from p
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Thank you for the question. To be totally honest, I am going to defer to the experts at VIDO-InterVac. The work we're doing will no doubt and hopefully support their very important and very good work, but we at Genome Canada are not in vaccine development in anything like the wa
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee The $40 million, broadly speaking, that is going to go to CanCOGeN is split into two pieces. There's a viral sequencing element and a human sequencing element. On the viral sequencing element, it's really designed to do two major things. One is to use the mutations that accumul
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee These investments at the intersection of genomics and health care are leading the shift from a disease-oriented system to one that is more precise, personalized, predictive and preventative. Genome Canada has been laying the foundation for its implementation in clinics across Can
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee Thank you, Mr. Chair. Thank you for the opportunity to speak to the committee. I am here on behalf of Genome Canada and I am joined today by Dr. Cindy Bell, who has been with Genome Canada since we were founded 20 years ago. It played an important science leadership role during
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee I'm also thinking of the millions of Canadians who make sacrifices every day to help fight COVID-19. We're all facing extreme uncertainty, but we're showing a great deal of strength and resilience. The challenges facing our world—in human health and disease, climate change and
April 30th, 2020Committee meeting
Dr. Rob Annan
Health committee I am happy to do it. Sorry about that. Why are we able to do this? It's because since 2000, the Government of Canada has made forward-looking investments to build Canadian genomics excellence through Genome Canada. I'll say a few words about who we are. Genome Canada is a uniqu
April 30th, 2020Committee meeting
Dr. Rob Annan